Summary
We report 32 biotinidase-deficient patients detected by family studies in the index cases. The study group consisted of 10 mothers, 4 fathers and 18 siblings. There were 17 individuals (3 mothers, 4 fathers and 10 siblings) with profound biotinidase deficiency (BD) (< 10% of mean normal activity) and 15 (7 mothers and 8 siblings) with partial BD (10–30% of mean normal activity). In the profound BD group, only three siblings were symptomatic. Dermatitis, microcephaly, developmental delay and convulsions were observed. The patients with partial BD did not have any clinical symptoms except one sibling with borderline IQ score. None of the parents was symptomatic. Family investigation of patients with BD is very important for the detection of asymptomatic patients who are at risk of exhibiting symptoms at any age. Careful evaluation of these untreated individuals with BD is important to obtain additional information about the natural history of this disorder and may provide clues to phenotype–genotype relationships and treatment regimes.
Similar content being viewed by others
References
Baumgartner ER, Suormala T (2000) Biotin-responsive multiple carboxylase deficiency. In: Fernandez J, Saudubray JM, van den Berghe G, eds. Inborn Metabolic Diseases, 3rd edn. Berlin: Springer, 277–282.
Baykal T, Huner G, Şarbat G, Demirkol M (1998) Incidence of biotinidase deficiency in Turkish newborns. Acta Paediatr 87: 1102–1102.
Diamantopoulos N, Painter MJ, Wolf B, Heard GS, Roe C (1986) Biotinidase deficiency: accumulation of lactate in the brain and response to physiologic dose of biotin. Neurology 36: 1107–1109.
Hymes J, Stanley CM, Wolf B (2001) Mutations in BTD causing biotinidase deficiency. Hum Mutat 18: 375–381.
Lott IT, Lottenberg S, Nyhan WL, Buchsbaum MJ (1993) Cerebral metabolic changes after treatment in biotinidase deficiency. J Inherit Metab Dis 16: 399–407.
Möslinger D, Stockler-Ipsiroglu S, Scheibenreiter S, et al (2001) Clinical and neuropsychological outcome in 33 patients with biotinidase deficiency ascertained by nationwide newborn screening and family studies in Austria. Eur J Pediatr 160: 277–282.
Möslinger D, Muhl A, Suormala T, Baumgartner R, Stockler-Ipsiroglu S (2003) Molecular characterisation and neuropsychological outcome of 21 patients with profound biotinidase deficiency detected by newborn screening and family studies. Eur J Pediatr 162: 46–49.
Muhl A, Moslinger D, Item CB, Stockler-Ipsiroglu S (2001) Molecular characterisation of 34 patients with biotinidase deficiency ascertained by newborn screening and family investigation. Eur J Hum Genet 9: 237–243
Norrgard KJ, Pomponio RJ, Hymes J, Wolf B (1999) Mutations causing profound biotinidase deficiency in children ascertained by newborn screening in the United States occur at different frequencies than in symptomatic children. Pediatr Res 46: 20–27.
Pispa J (1965) Animal biotinidase. Ann Med Exp Biol Fenn (Suppl) 43: 1–39.
Pomponio RJ, Reynolds TR, Cole H, Buck GA, Wolf B (1995) Mutational “hotspot” in the human biotinidase gene as a cause of biotinidase deficiency. Nature Genetics 11: 96-98.
Pomponio RJ, Hymes J, Reynolds TR, et al (1997) Mutations in the human biotinidase gene that cause profound biotinidase deficiency in symptomatic children: molecular, biochemical and clinical analysis. Pediatr Res 42: 840–848.
Pomponio RJ, Coskun T, Demirkol M, et al (2000) Novel mutations cause biotinidase deficiency in Turkish children. J Inherit Metab Dis 23: 120–128.
Rahman S, Standing S, Dalton RN, Pike MG (1997) Late presentation of biotinidase deficiency with acute visual loss and gait disturbance. Dev Med Child Neurol 39: 830–831.
Ramaekers VT, Suormala TM, Brab M, et al (1992) A biotinidase Km variant causing late-onset bilateral optic neuropathy. Arch Dis Child 67: 115–119.
Suormala T, Ramaekers VT, Schweitzer S, et al (1995) Biotinidase Km-variants: detection and detailed biochemical investigations. J Inherit Metab Dis 18: 689–700.
Suormala TM, Baumgartner ER, Wick H, Scheibenreiter S, Schweitzer S (1990) Comparison of patients with complete and partial biotinidase deficiency: biochemical studies. J Inherit Metab Dis 13: 76–92.
Tokatli A, Coşkun T, Ozalp I (1997) Biotinidase deficiency with neurologic features resembling multiple sclerosis. J Inherit Metab Dis 20: 707–708.
Wastell HJ, Bartlett K, Dale G, Shein A (1988) Biotinidase deficiency: a survey of 10 cases. Arch Dis Child 63: 1244–1249.
Wiznitzer M, Bangert BA (2003) Biotinidase deficiency: clinical and MRI findings consistent with myelopathy. Pediatr Neurol 29: 56–58.
Wolf B, Grier RE, Allen RJ, Goodman SI, Kien CL (1983a) Biotinidase deficiency: the enzymatic defect in late-onset multiple carboxylase deficiency. Clin Chim Acta 131: 273–281.
Wolf B, Grier RE, Allen RJ, et al (1983b) Phenotypic variation in biotinidase deficiency. J Pediatr 103: 233–237.
Wolf B, Heard GS, McVoy JS, Raetz HM (1984) Biotinidase deficiency: the possible role of biotinidase in the processing of dietary protein-bound biotin. J Inherit Metab Dis 7 (Supplement): 121.
Wolf B (1991) Worldwide survey of neonatal screening for biotinidase deficiency. J Inherit Metab Dis 14: 923–927.
Wolf B, Norrgard K, Pomponio RJ, et al (1997) Profound biotinidase deficiency in two asymptomatic adults. Am J Med Genet 73: 5–9.
Wolf B (1998) Disorders of biotin metabolism. In: Scriver CR, Beaudet AV, Sly WS, Valle D, eds Childs B, Kinzler KW, Vogelstein B, assoc. eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 3151–3177.
Wolf B, Pomponio RJ, Norrgard KJ, et al (1998) Delayed-onset profound biotinidase deficiency. J Pediatr 132: 362–365.
Wolf B (2003) Biotinidase deficiency: new directions and practical concerns. Curr Treat Options Neurol 5: 321–328.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Baykal, T., Gokcay, G., Gokdemir, Y. et al. Asymptomatic adults and older siblings with biotinidase deficiency ascertained by family studies of index cases. J Inherit Metab Dis 28, 903–912 (2005). https://doi.org/10.1007/s10545-005-0161-3
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10545-005-0161-3